These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 17914097)
1. Anthropometric measures, plasma adiponectin, and breast cancer risk. Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097 [TBL] [Abstract][Full Text] [Related]
2. Adipocytokine resistin and breast cancer risk. Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966 [TBL] [Abstract][Full Text] [Related]
3. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738 [TBL] [Abstract][Full Text] [Related]
4. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122 [TBL] [Abstract][Full Text] [Related]
5. Association of serum adiponectin levels with breast cancer risk. Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554 [TBL] [Abstract][Full Text] [Related]
6. Adipocytokines and breast cancer risk. Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478 [TBL] [Abstract][Full Text] [Related]
7. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Moorman PG; Hulka BS; Hiatt RA; Krieger N; Newman B; Vogelman JH; Orentreich N Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):483-8. PubMed ID: 9641492 [TBL] [Abstract][Full Text] [Related]
8. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Kim Y; Park SK; Han W; Kim DH; Hong YC; Ha EH; Ahn SH; Noh DY; Kang D; Yoo KY Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):508-15. PubMed ID: 19190159 [TBL] [Abstract][Full Text] [Related]
9. Measures of adiposity and risk of breast cancer in older postmenopausal women. Krebs EE; Taylor BC; Cauley JA; Stone KL; Bowman PJ; Ensrud KE J Am Geriatr Soc; 2006 Jan; 54(1):63-9. PubMed ID: 16420199 [TBL] [Abstract][Full Text] [Related]
10. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA; J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216 [TBL] [Abstract][Full Text] [Related]
11. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346 [TBL] [Abstract][Full Text] [Related]
12. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Tworoger SS; Sluss P; Hankinson SE Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055 [TBL] [Abstract][Full Text] [Related]
13. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378 [TBL] [Abstract][Full Text] [Related]
14. Association between adiponectin, insulin resistance, and endometrial cancer. Soliman PT; Wu D; Tortolero-Luna G; Schmeler KM; Slomovitz BM; Bray MS; Gershenson DM; Lu KH Cancer; 2006 Jun; 106(11):2376-81. PubMed ID: 16639730 [TBL] [Abstract][Full Text] [Related]
15. Higher levels of central adiposity in healthy premenopausal women with family histories of premenopausal breast cancer. Dettenborn L; James GD; Britton JA; Bovbjerg DH Am J Hum Biol; 2008; 20(3):355-8. PubMed ID: 18161037 [TBL] [Abstract][Full Text] [Related]
16. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. Tworoger SS; Eliassen AH; Sluss P; Hankinson SE J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279 [TBL] [Abstract][Full Text] [Related]
17. Anthropometry and breast cancer risk in Nigerian women. Okobia MN; Bunker CH; Zmuda JM; Osime U; Ezeome ER; Anyanwu SN; Uche EE; Ojukwu J; Kuller LH Breast J; 2006; 12(5):462-6. PubMed ID: 16958966 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters. Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732 [TBL] [Abstract][Full Text] [Related]
19. Relation between insulin resistance and breast cancer among Chilean women. Garmendia ML; Pereira A; Alvarado ME; Atalah E Ann Epidemiol; 2007 Jun; 17(6):403-9. PubMed ID: 17531933 [TBL] [Abstract][Full Text] [Related]
20. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]